Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Sandrine Henard is active.

Publication


Featured researches published by Sandrine Henard.


PLOS ONE | 2015

Cancer-Related Causes of Death among HIV-Infected Patients in France in 2010: Evolution since 2000

M.-A. Vandenhende; Caroline Roussillon; Sandrine Henard; Philippe Morlat; Eric Oksenhendler; Hugues Aumaitre; Aurore Georget; Thierry May; Eric Rosenthal; Dominique Salmon; Patrice Cacoub; Dominique Costagliola; Geneviève Chêne; Fabrice Bonnet

Objectives The current study aimed at describing the distribution and characteristics of malignancy related deaths in human immunodeficiency virus (HIV) infected patients in 2010 and at comparing them to those obtained in 2000 and 2005. Methods Data were obtained from three national surveys conducted in France in 2010, 2005 and 2000. The underlying cause of death was documented using a standardized questionnaire fulfilled in French hospital wards involved in the management of HIV infection. Results Among the 728 deaths reported in 2010, 262 were cancer-related (36%). After a significant increase from 28% in 2000 to 33% in 2005 and 36% in 2010, cancers represent the leading cause of mortality in HIV infected patients. The proportion of deaths attributed to non-AIDS/non-hepatitis-related cancers significantly increased from 2000 to 2010 (11% of the deaths in 2000, 17% in 2005 and 22% in 2010, p<0.001), while those attributed to AIDS-defining cancers decreased during the same period (16% in 2000, 13% in 2005 and 9% in 2010, p = 0.024). Particularly, the proportion of respiratory cancers significantly increased from 5% in 2000 to 6% in 2005 and 11% in 2010 (p = 0.004). Lung cancer was the most common cancer-related cause of death in 2010 (instead of non-Hodgkin lymphoma so far) and represented the leading cause of death in people living with HIV overall. Conclusions Cancer prevention (especially smoking cessation), screening strategies and therapeutic management need to be optimized in HIV-infected patients in order to reduce mortality, particularly in the field of respiratory cancers.


Journal of Clinical Microbiology | 2010

Probiotics and Intestinal Colonization by Vancomycin-Resistant Enterococci in Mice and Humans

Magali Vidal; Christiane Forestier; Nicolas Charbonnel; Sandrine Henard; Christian Rabaud; Olivier Lesens

ABSTRACT We investigated the impact of probiotics on the intestinal carriage of vancomycin-resistant enterococci (VRE). Administration of Lactobacillus rhamnosus Lcr35 but not Escherichia coli Nissle reduced, although not significantly, the density of VRE colonization in a murine model. No effect of Lcr35 was observed in a double-blind placebo randomized study, involving nine patients.


Antimicrobial Agents and Chemotherapy | 2013

Characterization of a New blaOXA-48-Carrying Plasmid in Enterobacteriaceae

Sibel Berger; Corentine Alauzet; Nejla Aissa; Sandrine Henard; Christian Rabaud; Richard Bonnet; Alain Lozniewski

ABSTRACT In this work, we characterized a new, 160-kb, blaOXA-48-harboring IncL/M-type plasmid isolated from a Klebsiella pneumoniae strain from France. Moreover, we report the transfer of a 60-kb OXA-48-encoding plasmid from Klebsiella pneumoniae to other Enterobacteriaceae in two patients.


Journal of Acquired Immune Deficiency Syndromes | 2012

Is total community viral load a robust predictive marker of the efficacy of the TasP strategy

Sandrine Henard; Eliette Jeanmaire; Yohan Nguyen; Yazdan Yazdanpanah; Antoine Cheret; Bruno Hoen; David Rey; Alice Borel; Pascal Chavanet; Thierry May; Christian Rabaud

Abstract:A mild but significant association between a decrease in the total community viral load (CVL) and a decrease in the number of new HIV diagnoses was observed between 2005 and 2010 in the population of northern and eastern France. This result suggests that CVL could be used as robust marker of the efficacy of the “Treatment as Prevention” strategy, and it may even be stronger if a large number of undiagnosed patients and early HIV infection cases indicated by extend screening are included in the CVL measurement.


American Journal of Infection Control | 2011

Evaluation of the duration of vanA vancomycin-resistant Enterococcus faecium carriage and clearance during a large-scale outbreak in a region of eastern France

Sandrine Henard; Alain Lozniewski; Nejla Aissa; Nathalie Jouzeau; Christian Rabaud

A monthly follow-up evaluation of vancomycin-resistant Enterococcus-colonized patients conducted during an outbreak in France revealed that carriage can persist for an extended period. Recurrence was observed despite as many as 3 negative cultures. As a result, we propose another definition for VRE clearance.


International Journal of Antimicrobial Agents | 2017

Impact of selective reporting of antibiotic susceptibility test results on the appropriateness of antibiotics chosen by French general practitioners in urinary tract infections: a randomised controlled case-vignette study

Loic Bourdellon; Nathalie Thilly; Sébastien Fougnot; Céline Pulcini; Sandrine Henard

Selective reporting of antibiotic susceptibility test (AST) results is a potential intervention for laboratory-based antibiotic stewardship. The aim of this study was to assess the impact of AST reporting on the appropriateness of antibiotics selected by French general practitioners for urinary tract infections (UTIs). A randomised controlled case-vignette study in a region of northeast France surveyed general practitioners between July and October 2015 on treatment of four clinical cases of community-acquired Escherichia coli UTIs (two cases of complicated cystitis, one of acute pyelonephritis and one male UTI). In Group A, selective reporting of AST results was used for the first two cases and complete reporting for the other two cases; these were reversed in Group B. The overall participation rate was 131/198 (66.2%). Provision of selective AST results significantly increased the rate of adherence to national guidelines for first-line antibiotic treatment in Cases 1, 3 and 4 by 22.4% (55.2% vs. 32.8%, P = 0.01), 67.5% (75.0% vs. 7.5%, P <0.001) and 36.3% (45.3% vs. 9.0%, P <0.001), respectively. The improvement in compliance was not significant for Case 2. Prescriptions of amoxicillin-clavulanic acid, fluoroquinolones and cephalosporins decreased by 25.0% to 45.0%, depending on the clinical vignette. Most (106/131, 81.0%) participants favoured the routine use of selective reporting of AST results. In conclusion, selective reporting of AST results seems to improve antibiotic prescribing practices in primary care, and may be considered a key element of antimicrobial stewardship programmes.


Scandinavian Journal of Infectious Diseases | 2012

Relevance of fluoroquinolone use in hospitals in the Lorraine region of France before and after corrective measures: An investigation by the Antibiolor network

Thanh Doco-Lecompte; Béatrice Demoré; Sandrine Henard; Lakshmi Rughoo; Christine Burty; Gregory Rondelot; Emilia Frentiu; Emmanuelle Desmots; Lorraine Letranchant; Celine Robert; Christian Rabaud; Thierry May

Objectives: This study of fluoroquinolone use was carried out before and after an educational intervention run by Antibiolor, a regional network to all hospitals in the Lorraine region of France. Methods: The relevance of fluoroquinolone prescription according to regional guidelines was assessed using a standard card filled out by physicians and pharmacists at the voluntarily participating hospitals. A therapeutic index of adequacy was established for each card. The initial survey took place in January 2008, with feedback and proposals for corrective measures in January 2009. The second survey was organized in June 2009. The results of the 2 surveys were compared. Results: Twenty-four hospitals completed a total of 1336 cards in the first survey (S1) and 944 cards in the second (S2). The appropriateness of indications for fluoroquinolone use improved by 57% between the 2 surveys. All the criteria analyzed (choice of drug, dosage, treatment duration) were significantly improved in S2 compared to S1, as was the adequacy index (70% improvement). Conclusions: In view of the consequences of fluoroquinolone use, many hospitals in Lorraine were keen to participate in this study, confirming its feasibility over a large area. In view of the study results, the book of guidelines was re-examined and republished at the conclusion of S2. Greater adherence to guidelines was noted in S2, demonstrating the benefit of assessing the situation thoroughly before proposing corrective measures and evaluating their impact.


Journal of Clinical Microbiology | 2014

Primary Cerebral Alveolar Echinococcosis: Mycology to the Rescue

Anne Debourgogne; François Goehringer; Gérald Umhang; Guillaume Gauchotte; Sandrine Henard; Franck Boué; Thierry May; Marie Machouart

ABSTRACT A case of primary cerebral alveolar echinococcosis with a favorable outcome is reported. A universal fungal PCR enabled this diagnosis, while the initial serological analysis remained noncontributive.


Cytometry Part B-clinical Cytometry | 2013

Value of HIV patients with regular follow‐up as in‐house internal controls of flow cytometry measurement of lymphocyte subsets

Marcelo de Carvalho Bittencourt; Chantal Kohler; Sandrine Henard; Christian Rabaud; Marie C. Béné; Gilbert C. Faure

Quality assessment in flow cytometry cannot obey the same rules as those applicable to the measurement of chemical analytes. However, regular follow‐up of known patients may provide a robust in‐house control of cell subsets evaluation.


International Journal of Hygiene and Environmental Health | 2011

Control of a regional outbreak of vanA glycopeptide-resistant Enterococcus faecium, Eastern France, 2004-2009

Sandrine Henard; Vincent Gendrin; Loïc Simon; Nathalie Jouzeau; Nathalie Vernier; Jean-Michel Thiolet; Bruno Coignard; Christian Rabaud

Collaboration


Dive into the Sandrine Henard's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Thierry May

University of Lorraine

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Antoine Cheret

Paris Descartes University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Bruno Coignard

Institut de veille sanitaire

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge